| 应用 |
A novel and potent cyclin-dependent kinase inhibitor for Cdk2, Cdk5, Cdk1, and Cdk9 |
| 产品介绍 |
Dinaciclib (SCH727965)是CDK抑制剂，对CDK2，CDK5，CDK1和CDK9的IC50分别为1 nM，1 nM，3 nM和4 nM。 |
| 备注 |
Dinaciclib (SCH727965) is a novel and potent CDK inhibitor for CDK2, CDK5, CDK1 and CDK9 with IC50 of 1 nM, 1 nM, 3 nM and 4 nM, respectively. It also blocks thymidine (dThd) DNA incorporation. Phase 3. |
| 生化机理 |
Dinaciclib(SCH 727965 ) is a pyrazolo[1,5-a]pyrimidine with potential antineoplastic activity. Dinaciclib(SCH 727965 ) selectively inhibits cyclin dependent kinases CDK1, CDK2, CDK5, and CDK9; inhibition of CDK1 and CDK2 may result in cell cycle repression and tumor cell apoptosis. |
| 别名 |
SCH 727965; (2S)-1-(3-乙基-7-(((1-氧代-3-吡啶基)甲基)氨基)吡唑并(1,5-a)嘧啶-5-基)-2-哌啶乙醇;;SCH727965; SCH-727965;(2s)-1-(3-ethyl-7-(((1-oxido-3-pyridinyl)methyl)amino)pyrazolo(1,5-a)pyrimidin-5-yl)-2-piperidineethanol |
![O-三环[5.2.1.0 2,6 ] 癸基-9-二硫代碳酸酯 钾盐](http://img.antpedia.com/cbook/attachments/product/6751/D127393.gif!w456x328.gif)
